Catalyst Wire Dossier Catalyst Wire Dossier

Epion Therapeutics (epithelium-on corneal cross-linking)

· Epion Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Epion Therapeutics (epithelium-on corneal cross-linking), covering 2026-06-25 to 2026-06-25. Get the full timeline:

Most recent: Clinical Trial Update: Epithelium-On Corneal Cross-linking in Subjects 8 to 45 Years of Age With Keratoconus [Phase 3]

See pricing